Table 4

MPTP/MPP+ kinetics in frontal cortex, hippocampus, and cerebellum at seven different time intervals

Frontal CortexHippocampusCerebellum
MPTPDSP-4 + MPTPMPTPDSP-4 + MPTPMPTPDSP-4 + MPTP
10 min
MPTP206.2  ± 13.9228.4  ± 17.2138.9  ± 11.4113.1  ± 8.7131.8  ± 11.9121.4  ± 13.1
MPP+ 3.2  ± 0.43.5  ± 0.123.3  ± 2.623.1  ± 1.78.9  ± 1.67.1  ± 1.6
30 min
MPTP/68.1  ± 5.24-a /81.4  ± 9.14-a /84.2  ± 9.84-a
MPP+ 42.2  ± 4.914.7  ± 2.64-a 37.6  ± 2.916.8  ± 1.94-a 36.8  ± 5.935.5  ± 4.7
1 h
MPTP/26.3  ± 8.54-a ////
MPP+ 2.6  ± 2.016.8  ± 2.44-a 29.5  ± 3.834.5  ± 4.124.4  ± 2.712.6  ± 3.44-a
2 h
MPP+ 76.2  ± 6.3140.6  ± 11.74-a 38.4  ± 3.536.1  ± 2.04.4  ± 0.25.8  ± 0.6
4 h
MPP+ 23.2  ± 3.457.8  ± 3.74-a /32.4  ± 2.74-a //
6 h
MPP+ /55.2  ± 4.64-a /17.8  ± 1.24-a //
12 h
MPP+ //////

MPTP and MPP+ levels at seven different time intervals after the administration of MPTP (30 mg/kg). Three days before MPTP administration, mice were injected with either saline or DSP-4 (50 mg/kg) to produce a selective lesion of NE terminals arising from the LC. Results are obtained from 10 animals sacrificed at each time interval from each group and are expressed as the mean ± S.E.M. Differences among groups were evaluated using ANOVA with Sheffé’s test.

  • 4-a P < .05 compared with MPTP.